TGIF2LX
gene geneOn this page
Summary
TGIF2LX (TGFB induced factor homeobox 2 like X-linked, HGNC:18570) is a protein-coding gene on chromosome Xq21.31, encoding Homeobox protein TGIF2LX (Q8IUE1). May have a transcription role in testis.
This gene encodes a member of the TALE/TGIF homeobox family of transcription factors. Testis-specific expression suggests that this gene may play a role in spermatogenesis. A homolog of this gene lies within the male specific region of chromosome Y, in a block of sequence that is thought to be the result of a large X-to-Y transposition.
Source: NCBI Gene 90316 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 26 total
- MANE Select transcript:
NM_138960
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18570 |
| Approved symbol | TGIF2LX |
| Name | TGFB induced factor homeobox 2 like X-linked |
| Location | Xq21.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000153779 |
| Ensembl biotype | protein_coding |
| OMIM | 300411 |
| Entrez | 90316 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000283891, ENST00000561129
RefSeq mRNA: 1 — MANE Select: NM_138960
NM_138960
CCDS: CCDS14459
Canonical transcript exons
ENST00000283891 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001705388 | 89921908 | 89921968 |
| ENSE00001896421 | 89922065 | 89922883 |
Expression profiles
Bgee: expression breadth broad, 14 present calls, max score 92.20.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0105 / max 4.4804, expressed in 7 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 196875 | 0.0105 | 7 |
Top tissues by expression
127 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 92.20 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.88 | gold quality |
| testis | UBERON:0000473 | 73.05 | gold quality |
| left testis | UBERON:0004533 | 72.96 | gold quality |
| right testis | UBERON:0004534 | 70.60 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| duodenum | UBERON:0002114 | 33.53 | silver quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.04 | gold quality |
| liver | UBERON:0002107 | 28.81 | gold quality |
| tonsil | UBERON:0002372 | 28.63 | gold quality |
| monocyte | CL:0000576 | 28.26 | silver quality |
| leukocyte | CL:0000738 | 28.20 | silver quality |
| primary visual cortex | UBERON:0002436 | 27.78 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| cortex of kidney | UBERON:0001225 | 27.28 | silver quality |
| urinary bladder | UBERON:0001255 | 26.85 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| gall bladder | UBERON:0002110 | 25.98 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 25.89 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.82 |
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA1571.1 | TGIF2LX | TALE-type homeo domain factors |
JASPAR matrix evidence (PMIDs): PMID:8537382
Literature-anchored findings (GeneRIF, showing 4)
- Association of TGIFLX/Y mRNA expression with azoospermia in infertile men.( (PMID:18384077)
- most prostate tumors (73.5%) express at least one of these genes (TGIFLX and TGIFLY), although different patterns of mRNA expression were observed. These results suggest an association of TGIFLX/Y expression with the progression of prostate cancer. (PMID:18663611)
- To the best of our knowledge, this is the first report that proposes Nir1, Nir2, and Fhit genes might be regulated by homeodomain protein TGIF2LX in colorectal adenocarcinoma cells. (PMID:29960902)
- Regulation of long non-coding RNAs XIST and ROR induced by homeodomain protein TGIF2LX in colorectal cancer. (PMID:36510989)
Cross-species orthologs
12 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | pbx2 | ENSDARG00000019717 |
| danio_rerio | pbx4 | ENSDARG00000052150 |
| mus_musculus | Tgif2lx1 | ENSMUSG00000100133 |
| mus_musculus | Tgif2lx2 | ENSMUSG00000100194 |
| rattus_norvegicus | Tgif2lx2 | ENSRNOG00000029850 |
| drosophila_melanogaster | exd | FBGN0000611 |
| drosophila_melanogaster | hth | FBGN0001235 |
| drosophila_melanogaster | vis | FBGN0033748 |
| drosophila_melanogaster | achi | FBGN0033749 |
| caenorhabditis_elegans | WBGENE00000443 | |
| caenorhabditis_elegans | WBGENE00006796 | |
| caenorhabditis_elegans | WBGENE00017690 |
Paralogs (13): MEIS3 (ENSG00000105419), PBX4 (ENSG00000105717), TGIF2 (ENSG00000118707), MEIS2 (ENSG00000134138), MEIS1 (ENSG00000143995), PKNOX1 (ENSG00000160199), PKNOX2 (ENSG00000165495), PBX3 (ENSG00000167081), TGIF2LY (ENSG00000176679), TGIF1 (ENSG00000177426), PBX1 (ENSG00000185630), MEIS3P2 (ENSG00000188013), PBX2 (ENSG00000204304)
Protein
Protein identifiers
Homeobox protein TGIF2LX — Q8IUE1 (reviewed: Q8IUE1)
Alternative names: TGF-beta-induced transcription factor 2-like protein, TGFB-induced factor 2-like protein, X-linked, TGIF-like on the X
All UniProt accessions (1): Q8IUE1
UniProt curated annotations — full annotation on UniProt →
Function. May have a transcription role in testis.
Subcellular location. Nucleus.
Tissue specificity. Specifically expressed in adult testis.
Similarity. Belongs to the TALE/TGIF homeobox family.
RefSeq proteins (1): NP_620410* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001356 | HD | Domain |
| IPR008422 | KN_HD | Domain |
| IPR009057 | Homeodomain-like_sf | Homologous_superfamily |
| IPR050224 | TALE_homeobox | Family |
Pfam: PF05920
UniProt features (12 total): helix 4, region of interest 2, compositionally biased region 2, chain 1, DNA-binding region 1, sequence variant 1, turn 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 2DMN | SOLUTION NMR |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8IUE1-F1 | 68.59 | 0.30 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 28 (showing top):
ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, chrXq21, GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II, GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS, RATTENBACHER_BOUND_BY_CELF1, GOMF_DNA_BINDING_TRANSCRIPTION_REPRESSOR_ACTIVITY, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, GSE15750_WT_VS_TRAF6KO_DAY6_EFF_CD8_TCELL_DN, FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_DN, GOMF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY, GOMF_CIS_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING, PULVER_FOREY_PERTURB_ACCUMULATION_LG1, PULVER_FOREY_PERTURB_ATTRITION_G2_M
GO Biological Process (2): negative regulation of transcription by RNA polymerase II (GO:0000122), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (4): DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227), sequence-specific double-stranded DNA binding (GO:1990837), DNA binding (GO:0003677)
GO Cellular Component (2): chromatin (GO:0000785), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of transcription by RNA polymerase II | 2 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| transcription by RNA polymerase II | 1 |
| negative regulation of DNA-templated transcription | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| negative regulation of transcription by RNA polymerase II | 1 |
| DNA-binding transcription factor activity, RNA polymerase II-specific | 1 |
| DNA-binding transcription repressor activity | 1 |
| double-stranded DNA binding | 1 |
| sequence-specific DNA binding | 1 |
| nucleic acid binding | 1 |
| chromosome | 1 |
| cellular anatomical structure | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
676 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TGIF2LX | PABPC5 | Q96DU9 | 943 |
| TGIF2LX | PCDH11X | Q9BZA7 | 854 |
| TGIF2LX | TGFBI | Q15582 | 840 |
| TGIF2LX | RHOXF2 | Q9BQY4 | 599 |
| TGIF2LX | CPXCR1 | Q8N123 | 571 |
| TGIF2LX | C10orf120 | Q5SQS8 | 512 |
| TGIF2LX | SPRY3 | O43610 | 501 |
| TGIF2LX | TRIM42 | Q8IWZ5 | 476 |
| TGIF2LX | RHOXF2B | P0C7M4 | 476 |
| TGIF2LX | TXLNG | Q9NUQ3 | 474 |
| TGIF2LX | A0A087WUC5 | A0A087WUC5 | 458 |
| TGIF2LX | GTPBP6 | O43824 | 448 |
| TGIF2LX | VCX3B | Q9H321 | 448 |
| TGIF2LX | ZNF705A | Q6ZN79 | 434 |
| TGIF2LX | SATL1 | Q86VE3 | 433 |
IntAct
23 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| HDAC1 | ZNF609 | psi-mi:“MI:0914”(association) | 0.730 |
| RBBP7 | HAT1 | psi-mi:“MI:0914”(association) | 0.730 |
| TGIF2LY | PGP | psi-mi:“MI:0914”(association) | 0.640 |
| SINHCAF | TNRC18 | psi-mi:“MI:0914”(association) | 0.640 |
| MBL2 | TRMU | psi-mi:“MI:0914”(association) | 0.500 |
| TGIF2LX | LRRK2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| TGIF2LX | psi-mi:“MI:0915”(physical association) | 0.370 | |
| IFNA14 | TGIF2LX | psi-mi:“MI:0915”(physical association) | 0.370 |
| PPBP | TGIF2LX | psi-mi:“MI:0915”(physical association) | 0.370 |
| XCL1 | TGIF2LX | psi-mi:“MI:0915”(physical association) | 0.370 |
| TGIF2LX | TNRC18 | psi-mi:“MI:0914”(association) | 0.350 |
| DKK2 | ZZEF1 | psi-mi:“MI:0914”(association) | 0.350 |
| PCGF3 | POTEI | psi-mi:“MI:0914”(association) | 0.350 |
| DKK2 | LRP5 | psi-mi:“MI:0914”(association) | 0.350 |
| PDIA5 | MBL2 | psi-mi:“MI:0914”(association) | 0.350 |
| FUBP3 | PRSS2 | psi-mi:“MI:0914”(association) | 0.350 |
| RBBP4 | PHF20L1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (38): TGIF2LX (Affinity Capture-MS), TGIF2LX (Reconstituted Complex), TGIF2LX (Affinity Capture-MS), FAM60A (Affinity Capture-MS), UBE2W (Affinity Capture-MS), SAP30L (Affinity Capture-MS), ING1 (Affinity Capture-MS), FOXK1 (Affinity Capture-MS), BAHCC1 (Affinity Capture-MS), RCHY1 (Affinity Capture-MS), ING2 (Affinity Capture-MS), HDAC1 (Affinity Capture-MS), BRMS1 (Affinity Capture-MS), SUDS3 (Affinity Capture-MS), TGIF2LX (Affinity Capture-MS)
ESM2 similar proteins: A0A1B0GTS1, A0A1B0GWH4, A1A4L6, A1YGI6, A6NDR6, B8QB46, F1MJR8, F1QDF8, O35892, O35893, P09015, P15036, P15037, P23497, P52729, P59598, Q32NH9, Q3KRF1, Q3UM89, Q4G112, Q4V7E1, Q5M7N6, Q5ND04, Q5XIV2, Q5ZHX5, Q66IG8, Q6P1R3, Q6PCX9, Q6PJQ5, Q708W2, Q76I76, Q76I79, Q76N89, Q7M6U3, Q8AXQ4, Q8BVK9, Q8IUE0, Q8IUE1, Q8IWB6, Q8IXJ9
Diamond homologs: A1YGI6, A6NDR6, A8K0S8, A8WL06, B7ZRT8, O00470, O04136, O14770, O22300, O42261, O46339, O65685, O70477, P41779, P41817, P46606, P48000, P48001, P48002, P48731, P53147, P54269, P55347, P56659, P56660, P56664, P56665, P56669, P70284, P78412, P78413, P78414, P78415, P79937, P81067, P81068, P97367, P97368, Q0E3C3, Q0J6N4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
26 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 24 |
| Likely benign | 1 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
92 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:89921965:ACAGG:A | donor_loss | 0.9800 |
| X:89921967:AGGTG:A | donor_loss | 0.9800 |
| X:89921968:GGTGA:G | donor_loss | 0.9800 |
| X:89921969:G:GA | donor_loss | 0.9800 |
| X:89921970:T:A | donor_loss | 0.9800 |
| X:89922063:A:AG | acceptor_gain | 0.9800 |
| X:89922064:G:GA | acceptor_gain | 0.9800 |
| X:89922064:GTAAC:G | acceptor_gain | 0.9800 |
| X:89922064:GT:G | acceptor_gain | 0.9700 |
| X:89922064:GTA:G | acceptor_gain | 0.9600 |
| X:89922064:GTAA:G | acceptor_gain | 0.9400 |
| X:89922060:TATA:T | acceptor_loss | 0.9200 |
| X:89922061:ATAG:A | acceptor_loss | 0.9200 |
| X:89922062:T:G | acceptor_gain | 0.9200 |
| X:89922058:A:AG | acceptor_gain | 0.8900 |
| X:89922059:A:G | acceptor_gain | 0.8600 |
| X:89922089:G:C | acceptor_gain | 0.8600 |
| X:89922289:G:GT | donor_gain | 0.8500 |
| X:89922061:A:AG | acceptor_gain | 0.8200 |
| X:89921971:GAGAA:G | donor_loss | 0.8000 |
| X:89922087:TGG:T | acceptor_gain | 0.8000 |
| X:89921969:G:GG | donor_gain | 0.7900 |
| X:89922048:T:TA | acceptor_loss | 0.7500 |
| X:89922085:TATGG:T | acceptor_gain | 0.7100 |
| X:89922086:ATGGA:A | acceptor_gain | 0.7100 |
| X:89922087:T:TA | acceptor_gain | 0.7100 |
| X:89922060:T:G | acceptor_gain | 0.6600 |
| X:89921965:ACAG:A | donor_gain | 0.6500 |
| X:89922053:T:G | acceptor_loss | 0.6500 |
| X:89922052:A:AG | acceptor_loss | 0.6400 |
AlphaMissense
1579 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:89922383:T:A | W100R | 0.994 |
| X:89922383:T:C | W100R | 0.994 |
| X:89922385:G:C | W100C | 0.994 |
| X:89922385:G:T | W100C | 0.994 |
| X:89922386:T:C | F101L | 0.994 |
| X:89922388:T:A | F101L | 0.994 |
| X:89922388:T:G | F101L | 0.994 |
| X:89922289:G:C | W68C | 0.993 |
| X:89922289:G:T | W68C | 0.993 |
| X:89922317:C:T | P78S | 0.993 |
| X:89922279:T:A | L65H | 0.991 |
| X:89922287:T:A | W68R | 0.991 |
| X:89922287:T:C | W68R | 0.991 |
| X:89922360:T:C | L92S | 0.991 |
| X:89922387:T:C | F101S | 0.991 |
| X:89922403:A:C | R106S | 0.989 |
| X:89922403:A:T | R106S | 0.989 |
| X:89922279:T:C | L65P | 0.987 |
| X:89922404:C:A | R107S | 0.985 |
| X:89922405:G:C | R107P | 0.985 |
| X:89922282:G:C | R66P | 0.984 |
| X:89922318:C:A | P78H | 0.984 |
| X:89922334:G:C | K83N | 0.984 |
| X:89922334:G:T | K83N | 0.984 |
| X:89922395:G:C | A104P | 0.983 |
| X:89922398:C:A | R105S | 0.983 |
| X:89922288:G:C | W68S | 0.982 |
| X:89922755:G:C | A224P | 0.982 |
| X:89922317:C:A | P78T | 0.981 |
| X:89922384:G:C | W100S | 0.981 |
dbSNP variants (sampled 300 via entrez): RS1000242752 (X:89922123 G>C), RS1001514073 (X:89921244 G>A), RS1001566618 (X:89920687 G>A,T), RS1001795653 (X:89921637 G>A), RS1008364760 (X:89920379 C>T), RS1014280095 (X:89921708 G>A), RS1014747084 (X:89921282 G>A), RS1016665127 (X:89922883 A>C,G), RS1018217388 (X:89921841 GA>G), RS1020218595 (X:89920402 A>G), RS1020406990 (X:89921323 G>A,C), RS1020773306 (X:89921762 G>A), RS1025605737 (X:89922787 G>A), RS1027282705 (X:89920625 T>C), RS1032137265 (X:89921791 G>A)
Disease associations
OMIM: gene MIM:300411 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001613_5 | Antineutrophil cytoplasmic antibody-associated vasculitis | 9.000000e-14 |
| GCST010298_3 | Metopic nonsyndromic craniosynostosis | 6.000000e-07 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0008511 | metopic craniosynostosis |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | increases expression, affects methylation, decreases methylation | 2 |
| benzo(e)pyrene | decreases methylation | 1 |
| aflatoxin B2 | decreases methylation | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Methapyrilene | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): anti-neutrophil antibody associated vasculitis